|
End-of-day quote
Bulgaria S.E.
13/11/2026
|
5-day change | 1st Jan Change | ||
| 3.100 EUR | -0.96% |
|
-6.91% | +117.61% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.07B 1.84B 1.67B 1.54B 1.39B 2.62B 174B 2.72B 18.54B 7.35B 92.77B 6.91B 6.77B 294B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.61B 2.17B 1.96B 1.82B 1.64B 3.09B 204B 3.2B 21.82B 8.65B 109B 8.13B 7.96B 346B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | -0.96% | ||
| 1 week | -6.91% | ||
| Current month | -7.74% | ||
| 1 month | +17.42% | ||
| 3 months | +59.79% | ||
| 6 months | +63.16% | ||
| Current year | +117.61% |
| 1 week | 3.04 |  | 3.33 |
| 1 month | 2.74 | | 3.56 |
| Current year | 1.41 | | 3.56 |
| 1 year | 1.34 | | 3.56 |
| 3 years | 0.94 | | 3.56 |
| 5 years | 0.68 | | 3.56 |
| 10 years | 0.41 | | 3.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/20 A | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 9/30/20 A | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 9/29/20 A | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -6.91% | +124.51% | +152.64% | 1.84B | |
| -1.12% | -6.01% | -36.96% | +6.72% | 16.53B | |
| +0.12% | +5.91% | -9.01% | +15.31% | 7.1B | |
| +2.73% | +4.32% | -6.23% | +6.14% | 6.89B | |
| -2.39% | -7.90% | -51.61% | -40.64% | 5.88B | |
| +2.54% | -5.87% | +3.03% | -19.24% | 4.63B | |
| -22.13% | -3.64% | -35.73% | -45.18% | 4.43B | |
| +0.89% | -4.84% | +8.49% | -19.49% | 3.49B | |
| +0.74% | +2.42% | -12.37% | -28.17% | 3.3B | |
| +3.43% | +6.62% | -20.60% | +37.24% | 3.3B | |
| Average | -1.62% | -0.24% | -3.65% | +6.53% | 6B | |
| Weighted average by Cap. | -1.47% | -1.16% | -17.70% | -0.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.16B 1.08B 972M 1.83B 121B 1.9B 12.94B 5.13B 64.72B 4.82B 4.72B 205B | 2.63B 1.58B 1.43B 1.33B 1.2B 2.25B 149B 2.33B 15.92B 6.31B 79.64B 5.93B 5.81B 253B |
| Net income | 77.85M 46.75M 42.37M 39.19M 35.36M 66.63M 4.41B 68.98M 471M 187M 2.35B 175M 172M 7.48B | 134M 80.19M 72.67M 67.22M 60.65M 114M 7.56B 118M 807M 320M 4.04B 301M 295M 12.82B |
| Net Debt | 444M 267M 242M 224M 202M 380M 25.15B 394M 2.69B 1.07B 13.44B 1B 980M 42.65B | 541M 325M 295M 272M 246M 463M 30.65B 480M 3.27B 1.3B 16.37B 1.22B 1.19B 51.97B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | €3.100 | -0.96% | 5,629 |
| 12/11/26 | €3.130 | -3.99% | 13,929 |
| 11/11/26 | €3.260 | -1.21% | 3,931 |
| 10/11/26 | €3.300 | +1.54% | 14,406 |
| 09/11/26 | €3.250 | -2.40% | 20,721 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
